A class of highly selective inhibitors bind to an active state of PI3Kγ

被引:43
|
作者
Gangadhara, Gangadhara [1 ]
Dahl, Goran [1 ]
Bohnacker, Thomas [2 ]
Rae, Rebecca [3 ]
Gunnarsson, Jenny [1 ]
Blaho, Stefan [1 ]
Oster, Linda [1 ]
Lindmark, Helena [1 ]
Karabelas, Kostas [3 ]
Pemberton, Nils [3 ]
Tyrchan, Christian [3 ]
Mogemark, Mickael [4 ]
Wymann, Matthias P. [2 ]
Williams, Roger L. [5 ]
Perry, Matthew W. D. [3 ]
Papavoine, Tineke [3 ]
Petersen, Jens [1 ]
机构
[1] AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden
[2] Univ Basel, Dept Biomed, Basel, Switzerland
[3] AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden
[4] AstraZeneca, IMED Biotech Unit, Drug Safety & Metab, Gothenburg, Sweden
[5] MRC Lab Mol Biol, Cambridge, England
基金
瑞士国家科学基金会; 英国医学研究理事会;
关键词
PHOSPHOINOSITIDE 3-KINASE GAMMA; KINASE; DISCOVERY; INFLAMMATION; ATHEROSCLEROSIS; DETERMINANTS; PI3K-DELTA; DISTINCT; OBESITY; POTENT;
D O I
10.1038/s41589-018-0215-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have discovered a class of PI3K gamma inhibitors exhibiting over 1,000-fold selectivity over PI3K alpha and PI3K beta. On the basis of X-ray crystallography, hydrogen-deuterium exchange-mass spectrometry and surface plasmon resonance experiments we propose that the cyclopropylethyl moiety displaces the DFG motif of the enzyme away from the adenosine tri-phosphate binding site, inducing a large conformational change in both the kinase- and helical domains of PI3K gamma. Site directed mutagenesis explained how the conformational changes occur. Our results suggest that these cyclopropylethyl substituted compounds selectively inhibit the active state of PI3K gamma, which is unique to these compounds and to the PI3K gamma isoform, explaining their excellent potency and unmatched isoform selectivity that were confirmed in cellular systems. This is the first example of a Class I PI3K inhibitor achieving its selectivity by affecting the DFG motif in a manner that bears similarity to DFG in/out for type II protein kinase inhibitors.
引用
收藏
页码:348 / +
页数:12
相关论文
共 50 条
  • [1] A class of highly selective inhibitors bind to an active state of PI3Kγ
    Gangadhara Gangadhara
    Göran Dahl
    Thomas Bohnacker
    Rebecca Rae
    Jenny Gunnarsson
    Stefan Blaho
    Linda Öster
    Helena Lindmark
    Kostas Karabelas
    Nils Pemberton
    Christian Tyrchan
    Mickael Mogemark
    Matthias P. Wymann
    Roger L. Williams
    Matthew W. D. Perry
    Tineke Papavoine
    Jens Petersen
    Nature Chemical Biology, 2019, 15 : 348 - 357
  • [2] Identification of highly potent and selective PI3Kδ inhibitors
    Marcoux, David
    Quin, Lan-Ying
    Ruan, Zheming
    Shi, Qing
    Ruan, Qian
    Weigelt, Carolyn
    Qiu, Hongchen
    Schieven, Gary
    Hynes, John
    Bhide, Rajeev
    Poss, Michael
    Tino, Joseph
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) : 2849 - 2853
  • [3] Highly delta selective quinazolinone PI3K inhibitors
    Treiberg, Jennifer
    Chandrasekhar, Jayaraman
    Ip, Carmen
    Koditek, David
    Lepist, Eve-Irene
    McGrath, Mary
    Mwangi, Judy
    Perreault, Stephane
    Somoza, John
    Steiner, Bart
    Therrien, Joseph
    Villasenor, Armando
    Wise, Sarah
    Wong, Belinda
    Phillips, Gary
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [4] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
    Jia, Hong
    Dai, Guangxiu
    Su, Weiguo
    Xiao, Kun
    Weng, Jianyang
    Zhang, Zhulin
    Wang, Qing
    Yuan, Tianhai
    Shi, Fuying
    Zhang, Zheng
    Chen, Wei
    Sai, Yang
    Wang, Jian
    Li, Xiong
    Cai, Yu
    Yu, Jun
    Ren, Ping
    Venable, Jennifer
    Rao, Tadimeti
    Edwards, James P.
    Bembenek, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948
  • [5] Discovery of novel class of alpha selective PI3K inhibitors
    Garland, Keira
    Hanan, Emily
    Staben, Steven
    Braun, Marie-Gabrielle
    Edgar, Kyle
    Endres, Nick
    Friedman, Lori
    Nguyen, Amanda
    Pang, Jodie
    Purkey, Hans
    Salphati, Laurent
    Schmidt, Stephen
    Song, Kyung
    Ultsch, Mark
    Jaochico, Allan
    Chan, Connie
    Eigenbrot, Charles
    MacLeod, Calum
    Jackson, Philip
    Narukulla, Raman
    Knight, Jamie
    Yeap, Kuen
    Messick, Kristen
    Valle, Nicole
    Heald, Robert
    Nannini, Michelle
    Hamilton, Pat
    Clausen, Saundra
    Young, Amy
    Sampath, Deepak
    Hong, Rebecca
    Lee, Man-Ling
    Blench, Toby
    Elliott, Richard
    Lu, Aijun
    Gu, Xiao-Hu
    Xin, Jianfeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [6] Highly Selective Inhibitors Of Pi3kγ For The Oral Treatment Of COPD
    Karabelas, K.
    Arlbrandt, S.
    Bold, P.
    Butcher, A.
    Carlsson, J. F.
    Cygan, P.
    Ehnebom, J.
    Goodyear, C.
    MacLellan, L.
    Nordberg, M.
    Lindmark, H.
    Mogemark, M.
    Pehrson, R.
    Perry, M.
    Blomqvist, S. R.
    Stern, A.
    Thomas, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Designing selective PI3K inhibitors
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2010, 9 : 105 - 105
  • [8] Designing selective PI3K inhibitors
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) : 105 - 105
  • [9] Discovery of Potent and Selective PI3Kγ Inhibitors
    Drew, Samuel L.
    Thomas-Tran, Rhiannon
    Beatty, Joel W.
    Fournier, Jeremy
    Lawson, Kenneth, V
    Miles, Dillon H.
    Mata, Guillaume
    Sharif, Ehesan U.
    Yan, Xuelei
    Mailyan, Artur K.
    Ginn, Elaine
    Chen, Jie
    Wong, Kent
    Soni, Divyank
    Dhanota, Puja
    Chen, Pei-Yu
    Shaqfeh, Stefan G.
    Meleza, Cesar
    Pham, Amber T.
    Chen, Ada
    Zhao, Xiaoning
    Banuelos, Jesus
    Jin, Lixia
    Schindler, Ulrike
    Walters, Matthew J.
    Young, Stephen W.
    Walker, Nigel P.
    Leleti, Manmohan Reddy
    Powers, Jay P.
    Jeffrey, Jenna L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11235 - 11257
  • [10] Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors
    Han, Fangbin
    Lin, Songwen
    Liu, Peng
    Liu, Xiujie
    Tao, Jing
    Deng, Xiaobing
    Yi, Chongqin
    Xu, Heng
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (04): : 434 - 438